Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand

BACKGROUND: Sacubitril-valsartan is effective in reducing the N-terminal pro-B-type natriuretic peptide level of hospitalized patients with acute decompensated heart failure, with a high acquisition cost compared with enalapril treatment. OBJECTIVE: This study aimed to determine the cost utility of...

Descripción completa

Detalles Bibliográficos
Autores principales: Krittayaphong, Rungroj, Permsuwan, Unchalee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446182/
https://www.ncbi.nlm.nih.gov/pubmed/34533783
http://dx.doi.org/10.1007/s40261-021-01079-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446182/
https://www.ncbi.nlm.nih.gov/pubmed/34533783
http://dx.doi.org/10.1007/s40261-021-01079-6

Ejemplares similares